This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

​Merck KGaA agrees to buy Versum for $53 a share; Entegris deal cancelled

( April 12, 2019, 13:05 GMT | Official Statement) -- MLex Summary: Germany's Merck KGaA has agreed to buy US semiconductor materials maker Versum Materials for $53 a share in cash. Versum has meanwhile terminated its plan to merge with US rival Entegris. Merck and Versum said in a joint press release that they expected to close the deal in the second half of the year, and that the US antitrust “waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 . . .  has already expired.”Statement follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login